Sio Capital Management Lowered Its Sanofi Sa (Put) (SNY) Position; Synthetic Biologics (PP) Sentiment Is 0.96

August 27, 2017 - By Migdalia James

Sio Capital Management Llc decreased Sanofi Sa (Put) (SNY) stake by 5.99% reported in 2016Q4 SEC filing. Sio Capital Management Llc sold 13,380 shares as Sanofi Sa (Put) (SNY)’s stock rose 14.25%. The Sio Capital Management Llc holds 210,000 shares with $8.49 million value, down from 223,380 last quarter. Sanofi Sa (Put) now has $123.59 billion valuation. The stock increased 0.56% or $0.27 on August 25, reaching $48.7. About 627,542 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since August 27, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.

Pacific Potash Corporation, formerly Silver Lake Capital Corp., is a Canada exploration mining company. The company has market cap of $919,220. The Firm is involved in the acquisition, exploration and development of mineral properties, primarily focused on potash. It currently has negative earnings. The Firm is engaged in the process of acquiring and exploring its interest in the Amazonas Potash, Provost Potash property and Roam property, which are located in Brazil and Canada.

It closed at $0.035 lastly. It is down 0.00% since August 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 10 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Sanofi-aventis Sa had 16 analyst reports since October 15, 2015 according to SRatingsIntel. Piper Jaffray initiated the shares of SNY in report on Friday, September 23 with “Neutral” rating. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Hold” rating given on Thursday, May 11 by Berenberg. The firm has “Underperform” rating given on Thursday, December 10 by BNP Paribas. The rating was upgraded by Morgan Stanley to “Overweight” on Thursday, October 15. Barclays Capital upgraded Sanofi SA (ADR) (NYSE:SNY) on Thursday, May 12 to “Overweight” rating. The stock has “Neutral” rating by JP Morgan on Friday, April 21. The firm has “Hold” rating by HSBC given on Tuesday, May 3. Argus Research initiated Sanofi SA (ADR) (NYSE:SNY) on Thursday, April 6 with “Buy” rating. BNP Paribas upgraded the stock to “Neutral” rating in Tuesday, September 13 report. The firm has “Reduce” rating given on Friday, April 7 by HSBC.